Effects of SGLT2 inhibitors on cardiac function and health status in chronic heart failure: a systematic review and meta-analysis

被引:0
|
作者
Jiao Chen
Chunxia Jiang
Man Guo
Yan Zeng
Zongzhe Jiang
Dongmin Zhang
Mengqin Tu
Xiaozhen Tan
Pijun Yan
XunMei Xu
Yang Long
Yong Xu
机构
[1] the Affiliated Hospital of Southwest Medical University,Department of Endocrinology and Metabolism
[2] The Third Hospital of Mianyang,Department of Endocrinology
[3] Sichuan Mental Health Center,State Key Laboratory of Quality Research in Chinese Medicine
[4] Sichuan Clinical Research Center for Nephropathy,Faculty of Chinese Medicine
[5] Metabolic Vascular Disease Key Laboratory of Sichuan Province,undefined
[6] Macau University of Science and Technology,undefined
[7] Macau University of Science and Technology,undefined
来源
关键词
SGLT2 inhibitors; Cardiac function; Health status; Chronic Heart Failure; Meta-analysis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] EFFECT OF SGLT2 INHIBITORS ON LEFT VENTRICULAR REMODELING IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Usman, Muhammad Shariq
    Siddiqi, Tariq Jamal
    Coats, Andrew
    Rosano, Giuseppe
    Filippatos, Gerasimos
    Anker, Stefan D.
    Butler, Javed
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 346 - 346
  • [42] Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis
    Usman, Muhammad Shariq
    Bhatt, Deepak L.
    Hameed, Ishaque
    Anker, Stefan D.
    Cheng, Alice Y. Y.
    Hernandez, Adrian F.
    Jones, William Schuyler
    Khan, Muhammad Shahzeb
    Petrie, Mark C.
    Udell, Jacob A.
    Friede, Tim
    Butler, Javed
    LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (07): : 447 - 461
  • [43] Efficacy and safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with acute heart failure: a systematic review and meta-analysis
    Hou, Jingjin
    Ren, Li
    Hou, Qingbin
    Jia, Xiaodong
    Mei, Zhu
    Xu, Jiaxin
    Yang, Zheming
    Li, Yiming
    Yan, Chenghui
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
  • [44] Heart Failure Prognosis in Diabetic Patients on SGLT2 (Sodium-Glucose Cotransporter-2) Inhibitors: A Systematic Review and Meta-Analysis
    Nso, Nso
    Emmanuel, Kelechi
    Nassar, Mahmoud
    Ayinde, Hakeem
    CIRCULATION, 2021, 144
  • [45] A systematic review and meta-analysis of SGLT-2 inhibitors in heart failure with a normal ejection fraction
    Singh, Surjit
    Shukla, Ravindra
    Sachin, J.
    Anil, Abhishek
    Dwivedi, Pradeep
    Varthya, Shoban Babu
    Kaur, Manbir
    Chugh, Vinay Kumar
    Khera, Daisy
    Chugh, Ankita
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 138 - 139
  • [46] Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trials
    Lee, Mei-Chuan
    Hua, Yi-Ming
    Yang, Chun-Ting
    Kuo, Fang-Hsiu
    Chang, Wei-Ting
    Tang, Hsin-Ju
    Toh, Han Siong
    Lin, Yu-Min
    Chen, Sih-Yao
    Chang, Hung-Yu
    Liao, Chia-Te
    MEDICINE, 2022, 101 (51) : E32489
  • [47] SGLT2 inhibitors reduce sudden cardiac death risk in heart failure: Meta-analysis of randomized clinical trials
    Oates, Connor P.
    Santos-Gallego, Carlos G.
    Smith, Alex
    Basyal, Binaya
    Moss, Noah
    Kawamura, Iwanari
    Musikantow, Daniel R.
    Turagam, Mohit K.
    Miller, Marc A.
    Whang, William
    Dukkipati, Srinivas R.
    Reddy, Vivek Y.
    Koruth, Jacob S.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2023, 34 (05) : 1277 - 1285
  • [48] IMPACT OF BASELINE KIDNEY FUNCTION ON SGLT2 INHIBITOR EFFECTS ON RENAL AND HEART FAILURE OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Cavallari, Ilaria
    La Porta, Ylenia
    Maddaloni, Ernesto
    Appetecchia, Alessandro
    D'onofrio, Luca
    Grigioni, Francesco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
  • [49] Commentary: Cardiovascular Outcome in Patients Treated With SGLT2 Inhibitors for Heart Failure: A Meta-Analysis
    Qiu, Mei
    Zhao, Li-Min
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [50] Long-term surrogate cardiovascular outcomes of SGLT2 inhibitor empagliflozin in chronic heart failure: a systematic review and meta-analysis
    Yan, Qingkai
    Chen, Xinrao
    Yu, Changqing
    Yin, Yuehui
    BMC CARDIOVASCULAR DISORDERS, 2024, 24 (01):